Platinum-Based Chemotherapy Secures Effective Local Control for Very Advanced Hereditary Triple-Negative Breast Cancer with Life-Threatening Bleeding

Research output: Contribution to journalArticlepeer-review

Abstract

Here we report the case of a noncompliant 50-year-old female patient with high-grade, triplenegative breast cancer (TNBC) and strong family cancer history. She only agreed to start treatment after being admitted to the hospital with advanced stage disease and severe anaemia resulting from bulky, ulcerated, and actively bleeding tumor. Therapy was promptly started with platinum-based chemotherapy, resulting in extremely rapid clinical remission and complete control of local symptoms. In conclusion, we hypothesise that even a single course of platinum-based chemotherapy could bring under control life-threatening complications in hereditary TNBC and, therefore, it should be administered without hesitation in emergency circumstances if the patient can tolerate one dose of the medication.
Original languageEnglish
Article numbere1455
Number of pages7
JournalEuropean Journal of Cancer
Volume9
Issue number7
DOIs
Publication statusPublished - Jul 2017

Keywords

  • breast cancer
  • platinum-based chemotherapy
  • response to chemotherapy
  • chemotherapy
  • neoadjuvant chemotherapy
  • triple negative breast cancer
  • hereditary breast cancer
  • bleeding breast cancer
  • breast cancer local control

Field of Science

  • 3.2 Clinical medicine

Publication Type

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Platinum-Based Chemotherapy Secures Effective Local Control for Very Advanced Hereditary Triple-Negative Breast Cancer with Life-Threatening Bleeding'. Together they form a unique fingerprint.

Cite this